v3.26.1
Stockholders' Equity (Tables)
 6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of Stock Options A summary of the Company’s stock option activity for its Plans is as follows:
Outstanding
Stock Options
(in thousands)
Weighted-Average
Exercise Price
Weighted-Average
Remaining
Contractual Life
(in years)
Aggregate
Intrinsic Value
(in millions)
Balance as of December 31, 20251
4,786 $11.58 7.2$13.4 
Granted
581 $10.18 
Exercised(124)$5.77 
Cancelled/forfeited
(794)$10.95 
Balance as of June 30, 20261
4,449 $11.67 6.0$1.3 
Vested and exercisable as of June 30, 20261
2,939 $12.29 4.4$1.1 
______________
(1)Includes 0.2 million of stock options with both service-based and performance-based conditions.
Schedule of Weighted-Average Assumptions and Ranges of Fair Value of Common Stock
The per-share fair value of each stock option granted was determined on the date of grant using the following weighted-average assumptions:
Six Months Ended
June 30,
20262025
Expected volatility58.9%57.9%
Expected term (in years)6.16.0
Risk-free interest rate4.0%4.1%
Schedule of Outstanding Nonvested RSUs A summary of the Company’s outstanding nonvested RSUs for its Plans is as follows:
Number of Units
(in thousands)
Weighted-Average
Grant-Date
Fair Value
Nonvested as of December 31, 20251
5,070 $11.13 
Granted
2,666 $10.29 
Vested1
(1,141)$11.09 
Forfeited1
(746)$11.21 
Nonvested as of June 30, 2026
5,849 $10.75 
______________
(1)Includes less than 0.1 million of RSUs with both service-based and performance-based conditions.
Schedule of Stock-based Compensation Expense The Company recognized stock-based compensation under the Plans and ESPP as follows:
Three Months Ended
June 30,		Six Months Ended
June 30,
(in millions)2026202520262025
Research and development$1.3 $2.5 $3.2 $4.6 
Sales and marketing2.5 2.6 4.7 4.7 
General and administrative3.1 3.1 6.0 5.6 
Total Stock-based Compensation
$6.9 $8.2 $13.9 $14.9